Transport and permeability properties of dapivirine: understanding potential drug-drug interactions

被引：0
|
作者：
Zheng, R. [1 ]
Rohan, L. [1 ]
机构：
[1] Univ Pittsburgh, Pharmaceut Sci, Sch Pharm, Pittsburgh, PA USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
PE24.02
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Evaluation of potential drug-drug interactions in a pediatric population
    Bebitoglu, Berna Terzioglu
    Oguz, Elif
    Nuhoglu, Cagatay
    Dalkilic, Ayse Ela Kurtdan
    Cirtlik, Pelin
    Temel, Fatime
    Hodzic, Ajla
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2020, 55 (01): : 30 - 38
  • [32] Analysis of potential drug-drug interactions in hospitalized patients
    Wieczorek, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1550 - 1550
  • [33] Prevalence of potential drug-drug interactions in Slovenia in 2013
    Jazbar, Janja
    Locatelli, Igor
    Kos, Mitja
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (02) : 408 - 409
  • [34] Data mining for potential adverse drug-drug interactions
    Hammann, Felix
    Drewe, Juergen
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) : 665 - 671
  • [35] Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Vazquez, Marta
    Garcia-Carnelli, Carlos
    Maldonado, Cecilia
    Fagiolino, Pietro
    CANNABINOIDS AND SLEEP: MOLECULAR, FUNCTIONAL AND CLINICAL ASPECTS, 2021, 1297 : 27 - 42
  • [36] Potential severe drug-drug interactions in elderly patients
    Reactions Weekly, 2021, 1879 (1) : 9 - 9
  • [37] Milnacipran Has Low Potential for Drug-Drug Interactions
    Periclou, Antonia
    Coutts, Stephen M.
    Rao, Sriniuas G.
    Palmer, Robert H.
    Thacker, Kim
    Trugman, Joel
    NEUROLOGY, 2009, 72 (11) : A212 - A212
  • [38] A Minimal Information Model for Potential Drug-Drug Interactions
    Hochheiser, Harry
    Jing, Xia
    Garcia, Elizabeth A.
    Ayvaz, Serkan
    Sahay, Ratnesh
    Dumontier, Michel
    Banda, Juan M.
    Beyan, Oya
    Brochhausen, Mathias
    Draper, Evan
    Habiel, Sam
    Hassanzadeh, Oktie
    Herrero-Zazo, Maria
    Hocum, Brian
    Horn, John
    LeBaron, Brian
    Malone, Daniel C.
    Nytro, Oystein
    Reese, Thomas
    Romagnoli, Katrina
    Schneider, Jodi
    Zhang, Louisa
    Boyce, Richard D.
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [39] The serotonin syndrome, triptans, and the potential for drug-drug interactions
    Shapiro, Robert E.
    Tepper, Stewart J.
    HEADACHE, 2007, 47 (02): : 266 - 269
  • [40] TERIFLUNOMIDE: POTENTIAL FOR TRANSPORTER MEDIATED DRUG-DRUG INTERACTIONS
    Weitz, D.
    Schmider, W.
    Menguy-Vacheron, F.
    Clot, P.
    Hermabessiere, S.
    Jiang, J.
    Su, Y.
    Thuillier, V.
    Turpault, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S112 - S113
12345